statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the companys breakthrough RESILIA tissue...

Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability

Cramer likes Delta Air Lines, United Airlines Holdings. 'Now, remember, they're very inexpensive stocks, but they trade wildly. But I do like Delta,' he added.
read more...

Jim Cramer: These Airline Stocks 'Trade Wildly,' Edwards Lifesciences 'At The Right Level To Buy'

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2024. Highlights and Outlook Q1 sales grew 10% on a reported and constant currency1 basis to $1.6...

Edwards Lifesciences Reports First Quarter Results

Decoding Edwards Lifesciences's Options Activity: What's the Big Picture?

Behind the Scenes of Edwards Lifesciences's Latest Options Trends

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday, April 25, 2024, and will host a conference call at...

Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024

$1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today

Latest Ratings for EW
 DateFirmActionFromTo Feb 2022UBSUpgradesNeutralBuy Jan 2022Morgan StanleyMaintainsOverweight Jan 2022Raymond JamesMaintainsOutperform
 View More Analyst Ratings for EW...

What Analysts Are Saying About Edwards Lifesciences Stock

Edwards Lifesciences (NYSE: EW) announced the release of data from the HUDDLE study that examined the prevalence of heart disease and associated risk factors among members of the National Football...

Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It

Edwards Lifesciences (NYSE:EW - Get Free Report) had its price objective boosted by Evercore ISI from $86.00 to $92.00 in a research report issued to clients and investors on Thursday, Benzinga...

Edwards Lifesciences (NYSE:EW) PT Raised to $92.00 at Evercore ISI

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Watchers	4,615
52-Wk Low	$60.57
52-Wk High	$96.12

Volume	1.99M
52-Wk High	$96.12
52-Wk Low	$60.57

EW Edwards Lifesciences Corp

About

Feed

News

Sentiment

Earnings

Fundamentals